Molbio Diagnostics, SigTuple to build next-gen point-of-care diagnostic testing devices

The focus of the tie up is to reduce turnaround time for testing, reduce errors, and help in early diagnosis and initiation of correct treatment

Molbio Diagnostics has collaborated with SigTuple, a medtech startup in the field of AI for diagnostics, to build next-generation AI-enabled portable devices for many routines but critical diagnostic tests. These devices will enable testing to be performed at the point of care – a doctor’s chamber, a public health centre, or an emergency room of a hospital – without having to send samples to central laboratories. The aim is to reduce turnaround time for testing, reduce errors, and help in early diagnosis and initiation of correct treatment.

Molbio and SigTuple are joining hands to collaborate on the development of AI-powered, battery-operated, portable devices for many diagnostic tests in the fields of haematology, biochemistry, electrochemistry and others. The testing process will be extremely simplified and will not require a trained laboratory technician to perform the tests. Accurate, laboratory-quality test results will be available to the patient within a few minutes.

The collaboration builds on the strengths of the two organisations to drive cutting-edge technology which can make high-quality diagnostics accessible to everyone.

Sriram Natarajan, CEO, Director and Co-Founder, Molbio Diagnostics, said, “Molbio started with the vision to democratize access to high-quality diagnostics through innovative tools. Truenat, our point-of-care molecular platform, is already playing this role in the area of infectious diseases. However, there is still a gap in other critical areas. We are delighted to join with SigTuple in our Universal Access Mission and accelerate the development of the next-gen devices that will not only fill this gap but also provide instant reports through Artificial Intelligence to enable immediate intervention and create a positive impact on patient and societal well-being.”

Tathagato Rai Dastidar, Founder and CEO, SigTuple, said, “SigTuple started in 2015 with a singular goal – to make quality healthcare more accessible, more accurate and more affordable, with the help of AI, robotics and microfluidics. While our other products are meant for clinical laboratories, with this new product, we will be able to push the boundaries of diagnostics much nearer to the end patient. We are truly honoured and excited to partner with Molbio, a proven leader in portable diagnostic devices, in building this product. Together, we will be able to bring this revolutionary technology into the market faster. The partnership is also a strong vote of confidence in the technological prowess of SigTuple.”